Lombard Odier Asset Management (Europe)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.9M | Sell |
44,489
-1,463
| -3% | -$794K | 1.18% | 14 |
|
|
2025
Q4 | $26.6M | Sell |
45,952
-289,518
| -86% | -$164M | 1.32% | 11 |
|
|
2025
Q3 | $30.1M | Buy |
335,470
+301,656
| +892% | +$140M | 1.52% | 19 |
|
|
2025
Q2 | $13.7M | Sell |
33,814
-3,657
| -10% | -$1.53M | 0.96% | 31 |
|
|
2025
Q1 | $18.6M | Sell |
37,471
-13,870
| -27% | -$7.51M | 1.5% | 20 |
|
|
2024
Q4 | $26.7M | Sell |
51,341
-5,118
| -9% | -$2.81M | 1.72% | 7 |
|
|
2024
Q3 | $34.9M | Buy |
56,459
+6,533
| +13% | +$3.87M | 1.48% | 6 |
|
|
2024
Q2 | $27.6M | Buy |
49,926
+20,409
| +69% | +$11.7M | 1.31% | 10 |
|
|
2024
Q1 | $17.2M | Sell |
29,517
-8,629
| -23% | -$4.84M | 1.03% | 21 |
|
|
2023
Q4 | $20.2M | Sell |
38,146
-16,670
| -30% | -$8.07M | 1.17% | 20 |
|
|
2023
Q3 | $27.7M | Buy |
54,816
+2,405
| +5% | +$1.28M | 1.42% | 19 |
|
|
2023
Q2 | $27.3M | Buy |
52,411
+35,165
| +204% | +$19M | 1.29% | 16 |
|
|
2023
Q1 | $9.94M | Sell |
17,246
-2,157
| -11% | -$1.22M | 0.49% | 61 |
|
|
2022
Q4 | $10.7M | Buy |
19,403
+621
| +3% | +$329K | 0.43% | 69 |
|
|
2022
Q3 | $9.53M | Buy |
18,782
+12,966
| +223% | +$7.26M | 0.49% | 67 |
|
|
2022
Q2 | $3.16M | Buy |
+5,816
| New | +$3.2M | 0.16% | 147 |
|
|
2022
Q1 | – | Sell |
-4,537
| Closed | -$3.03M | – | 205 |
|
|
2021
Q4 | $3.03M | Buy |
+4,537
| New | +$2.83M | 0.13% | 110 |
|
|
2021
Q2 | – | Sell |
-659
| Closed | -$301K | – | 233 |
|
|
2021
Q1 | $301K | Buy |
+659
| New | +$315K | 0.02% | 178 |
|
|
2020
Q4 | – | Sell |
-3,590
| Closed | -$1.58M | – | 378 |
|
|
2020
Q3 | $1.58M | Buy |
+3,590
| New | +$1.48M | 0.09% | 98 |
|
|
2020
Q2 | – | Sell |
-3,590
| Closed | -$1.02M | – | 270 |
|
|
2020
Q1 | $1.02M | Sell |
3,590
-613
| -15% | -$193K | 0.08% | 119 |
|
|
2019
Q4 | $1.36M | Hold |
4,203
| – | – | 0.1% | 106 |
|
|
2019
Q3 | $1.22M | Hold |
4,203
| – | – | 0.1% | 108 |
|
|
2019
Q2 | $1.23M | Hold |
4,203
| – | – | 0.1% | 111 |
|
|
2019
Q1 | $1.15M | Buy |
4,203
+145
| +4% | +$36.1K | 0.11% | 104 |
|
|
2018
Q4 | $908K | Hold |
4,058
| – | – | 0.08% | 121 |
|
|
2018
Q3 | $990K | Hold |
4,058
| – | – | 0.07% | 135 |
|
|
2018
Q2 | $841K | Hold |
4,058
| – | – | 0.06% | 137 |
|
|
2018
Q1 | $838K | Sell |
4,058
-510
| -11% | -$107K | 0.06% | 137 |
|
|
2017
Q4 | $867K | Sell |
4,568
-533
| -10% | -$102K | 0.05% | 143 |
|
|
2017
Q3 | $965K | Hold |
5,101
| – | – | 0.06% | 137 |
|
|
2017
Q2 | $890K | Hold |
5,101
| – | – | 0.05% | 138 |
|
|
2017
Q1 | $784K | Sell |
5,101
-750
| -13% | -$115K | 0.04% | 138 |
|
|
2016
Q4 | $826K | Hold |
5,851
| – | – | 0.3% | 85 |
|
|
2016
Q3 | $931K | Hold |
5,851
| – | – | 0.32% | 78 |
|
|
2016
Q2 | $865K | Buy |
+5,851
| New | +$864K | 0.05% | 130 |
|
Other funds holding TMO
VCM
Lombard Odier Asset Management (Europe)'s TMO Position: Q1 2026 in Review
Lombard Odier Asset Management (Europe) reduced its Thermo Fisher Scientific (TMO) stake by 3.2% in Q1 2026, selling an estimated $794K and leaving 44,489 shares worth $21.9M. The position accounts for 1.18% of the portfolio, ranked #14.
Lombard Odier Asset Management (Europe) first reported a position in TMO in Q2 2016 and has held it in 35 quarters since. The position peaked at $34.9M in Q3 2024. 2,594 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Lombard Odier Asset Management (Europe) held 44,489 shares of Thermo Fisher Scientific worth $21.9M as of Q1 2026.
- Lombard Odier Asset Management (Europe) sold 1,463 Thermo Fisher Scientific shares in Q1 2026, an estimated $794K.
- Thermo Fisher Scientific made up 1.18% of Lombard Odier Asset Management (Europe)'s portfolio in Q1 2026, its #14 holding.
- Lombard Odier Asset Management (Europe) first reported a position in Thermo Fisher Scientific in Q2 2016 and has held it in 35 quarters since.
- Lombard Odier Asset Management (Europe)'s Thermo Fisher Scientific position peaked at $34.9M in Q3 2024.
- 2,594 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q1 2026, filed 15 May 2026.